Oral anticoagulant or antiplatelet medication use had no substantial effect on the accuracy of multitarget stool DNA testing for colorectal cancer, according to a study published in Gastro Hep ...
Investigators believe that this new anticoagulant, named tecarfarin, will be associated with less therapeutic variability than warfarin because its structure precludes it from being metabolized by ...
TAIPEI, Jan. 21, 2025 /CNW/ -- TAHO Pharmaceuticals is pleased to announce the successful completion of the pivotal trial for TAH3311, the first anticoagulant oral dissolving film (ODF). This trial ...